Supreme Courts of Singapore and Cambodia Sign Memorandum of Understanding for Judicial Cooperation [Accessibility Statement] Skip NavigationSINGAPORE, Feb. 18, 2026 /PRNewswire/ -- On 10 February 2026, the Supreme Court of the Republic of Singapore and the Supreme Court of the Kingdom of Cambodia signed a Memorandum of Understanding (MOU) to promote bilateral judicial cooperation.Continue ReadingOn 10 February 2026, The Honourable the Chief Justice Sundaresh Menon made a courtesy call on the President of th ...

Core Viewpoint - Boeing and Sun PhuQuoc Airways have announced an order for up to 40 787 Dreamliner jets, marking a significant step in enhancing tourism and economic growth on Phu Quoc Island, Vietnam [1] Group 1: Company Developments - Sun PhuQuoc Airways, Vietnam's first airline named after an island, aims to establish a world-class airline that integrates with the tourism ecosystem developed by Sun Group [1] - The airline plans to expand its fleet to 100 aircraft by 2030, positioning itself to capture the growing demand for premium tourism in Vietnam [1] Group 2: Aircraft Specifications and Benefits - The 787-9 Dreamliner has a range of 7,565 nautical miles (14,010 km), enabling efficient connections from Phu Quoc to major cities across Asia, Europe, and North America [1] - The aircraft is designed for superior passenger comfort, featuring the largest windows of any widebody airplane and lower cabin altitude pressurization, enhancing the travel experience [1] Group 3: Market Context - Southeast Asia is expected to experience significant air travel growth over the next 20 years, with Vietnam projected to be the fastest-growing aviation market in the region, anticipating nearly 8% annual passenger growth by 2030 [1] - The global fleet of 787 Dreamliners has launched over 535 new nonstop routes and carried more than 1.2 billion passengers since its introduction in 2011, contributing to enhanced global connectivity [1]

Group 1 - Ecopetrol S.A. plans to release its financial and operating results for Q4 2025 and the full year on March 4, 2026, after market close [1] - A virtual conference will be held on March 5, 2026, at 9:00 a.m. Colombia Time and New York Time, with simultaneous transmission in Spanish and English [1] - The company is the largest in Colombia, responsible for over 60% of the country's hydrocarbon production, and has significant roles in transportation, logistics, and refining [1] Group 2 - Ecopetrol has acquired 51.4% of ISA's shares, expanding its participation in energy transmission and real-time systems management [1] - The company has international operations in strategic basins across the Americas, including drilling and exploration in the U.S., Brazil, and Mexico [1] - Ecopetrol holds leading positions in power transmission in Brazil, Chile, Peru, and Bolivia, as well as in road concessions and telecommunications in Chile [1]

Core Viewpoint - A securities fraud class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. for alleged material misstatements regarding its drug setrusumab, affecting investors who purchased stock between August 3, 2023, and December 26, 2025 [1] Summary by Relevant Sections Lawsuit Details - The lawsuit is filed in the United States District Court for the Northern District of California, under the case name Bailey v. Ultragenyx Pharmaceutical Inc., et al, Case No. 3:26-cv-01097 (N.D. Cal.) [1] - Investors have until April 6, 2026, to file for lead plaintiff status [1] Allegations - The complaint alleges that Ultragenyx misrepresented the reliability of information regarding the effects of setrusumab on patients with Osteogenesis Imperfecta, downplaying the risk of failure in achieving statistically significant results in the Phase III Orbit study [1] - It is claimed that Ultragenyx's optimism regarding the study's results was unfounded, as the Phase II results lacked a placebo control group, raising concerns about the validity of the reported reduction in annualized fracture rate (AFR) [1] - The lawsuit asserts that the positive statements made by the company about its business and prospects were materially misleading and lacked a reasonable basis [1] Investor Actions - Investors can retain counsel of their choice, contact Kessler Topaz Meltzer & Check, LLP for a free case evaluation, or file to be lead plaintiff by the April 6, 2026 deadline [1] - The lead plaintiff will represent all class members in directing the litigation and is typically the investor or group of investors with the largest financial interest [1]

Core Viewpoint - Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against uniQure N.V. on behalf of investors who purchased shares between September 24, 2025, and October 31, 2025, alleging material misstatements regarding the company's Huntington's disease gene therapy drug [1]. Group 1: Lawsuit Details - The lawsuit, titled Scocco v. uniQure N.V., was filed in the United States District Court for the Southern District of New York [1]. - The class period for the lawsuit is defined as September 24, 2025, to October 31, 2025, with a deadline for investors to seek lead plaintiff status by April 13, 2026 [1]. - The allegations include misleading statements about the Phase I/II clinical trials of uniQure's leading drug candidate, AMT-130, and the timeline for its Biologics License Application (BLA) submission to the FDA [1]. Group 2: Allegations Against uniQure - The complaint claims that uniQure misrepresented the approval status of the Pivotal Study design by the FDA and downplayed the likelihood of delays in the BLA timeline due to the need for additional studies [1]. - It is alleged that the defendants failed to disclose material adverse facts about uniQure's business and operations, leading to a lack of reasonable basis for their statements regarding the company's prospects [1]. Group 3: Investor Actions - Investors affected by the alleged fraud are encouraged to contact Kessler Topaz Meltzer & Check, LLP for a free case evaluation and to consider filing to be a lead plaintiff by the specified deadline [1]. - The lead plaintiff process allows investors to represent the class in directing the litigation, with the potential for recovery not affected by the decision to serve as lead plaintiff [1].

Core Insights - Vietnam Airlines has finalized an order for 50 Boeing 737 MAX airplanes, marking its first single-aisle order from Boeing as part of its growth strategy to expand its domestic and regional route network amid rising travel demand in Southeast Asia [1] Group 1: Company Strategy - The order for the 737-8 aircraft is part of Vietnam Airlines' comprehensive approach to strengthen its capabilities, including fleet modernization and financial resilience, to support long-term growth ambitions [1] - The investment in the 737-8 aircraft aims to build a modern, fuel-efficient fleet, enhance operational performance, and elevate service standards to meet international benchmarks [1] Group 2: Market Context - Vietnam's air traffic is projected to double to over 75 million annual passengers in the next 10 years, necessitating the introduction of reliable and high-capacity aircraft like the 737-8 [1] - The 737-8 can carry up to 200 passengers and has a range of up to 3,500 nautical miles (6,480 km), making it suitable for the airline's short- and medium-haul network expansion [1] Group 3: Partnership with Boeing - The agreement deepens the strategic partnership between Vietnam Airlines and Boeing, supporting the airline's ambition to become a five-star international airline by 2030 [1] - The combination of the 737 MAX and the existing 787 Dreamliners is expected to deliver a 20-25% improvement in fuel efficiency compared to the aircraft they replace, aiding in network expansion while lowering operating costs [1]

Roland DGA Announces Launch of New UV DTF System with Enhanced Media [Accessibility Statement] Skip NavigationIRVINE, Calif., Feb. 18, 2026 /PRNewswire/ -- Leading wide-format digital imaging provider Roland DGA has announced the launch of a new UV Direct-to-Film (DTF) system, featuring enhanced media that significantly improves ease of use, productivity, and versatility compared to previous UV DTF products.Continue ReadingRoland DGA's new UV DTF system is designed to make customizing and personalizing a wi ...

Core Insights - Dr. Chinyere "Dr. Chi" Johnson's video series on her infertility journey has gained over 10 million views in 30 days, highlighting the urgent need for discussions on medical dismissal and maternal health disparities faced by Black women [1][1][1] Group 1: Healthcare Disparities - Black women in the U.S. are nearly three times more likely to die from pregnancy-related causes compared to white women, often due to delayed recognition of complications and inequitable care [1][1] - A 2016 study indicated that some medical trainees hold false beliefs about biological differences between Black and white patients, impacting pain assessment and treatment recommendations [1][1] - Research shows that Black women are more likely than white women to report that medical providers do not listen carefully or take their concerns seriously [1][1] Group 2: Community Response - Dr. Chi's series has prompted thousands of women to share their own experiences with infertility, revealing a common struggle that is often not openly discussed [1][1] - Messages from women reflect the emotional toll of infertility, with many expressing feelings of isolation and the need for hope [1][1] - Dr. Chi emphasizes the importance of improvement in healthcare, advocating for women to be heard and providing educational tools to navigate their care confidently [1][1] Group 3: Professional Background - Dr. Chi is a Houston-based family medicine physician and mental health advocate who has personally experienced infertility and the challenges of being unheard in the healthcare system [1][1] - Her candid approach combines medical expertise with personal experience, empowering women to advocate for their health and mental well-being [1][1] - The significant viewership of her series indicates a deeper issue within the healthcare system that requires attention and action [1][1]

Genicom to Showcase High-Temperature UV Sensor Solutions at AFPE 2026 in Shanghai [Accessibility Statement] Skip Navigation- Strengthening its industrial UV measurement portfolio for global smart factory markets- Delivering stable UV measurement in extreme environments up to 250°C with GaN-based technologySEOUL, South Korea, Feb. 18, 2026 /PRNewswire/ -- Genicom Co., Ltd. (CEO Jung-hwan Son), a specialist in ultraviolet (UV) detection and measurement technologies, announced its participation in AFPE 2026 (A ...

PYPL Investors Have Opportunity to Lead PayPal Holdings, Inc. Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of PayPal Holdings, Inc. (NASDAQ: PYPL) between February 25, 2025 and February 2, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move ...